For Healthcare CPG, DTC Pharma & OTC Brand Teams

Run continuous brand and HCP research within one subscription

Hims, Ro, Figs, Hoka medical, OTC brands targeting clinicians and patients: verified clinician panel, AI-moderated voice and video interviews, HIPAA-compliant by default, BAA + Sunshine Act handling on every HCP engagement. Monthly subscription with 50 interviews included — always-on brand health and HCP audience research without sacrificing rigor.

Monthly subscription with 50 interviews included; always-on listening capability
BAA + Sunshine Act-ready on every HCP engagement
0.4% verified AI-respondent leak rate
Verified clinician on a Carevoices research interview
Live

Trusted by teams at

Nivella Health
TL;DR

Healthcare CPG, DTC pharma, and OTC brand teams (Hims, Ro, Figs) face three constraints generic CPG research tools don't solve: HCP audience recruitment requires license + NPI verification generic panels can't honor; HCP work triggers BAA and Sunshine Act handling generic vendors can't sign; and SKU launch and creative cycles outrun legacy panel cadence. Carevoices delivers AI-moderated voice/video interviews with verified clinicians by specialty and workplace setting plus HCP audiences — recruited in 7-21 days, HIPAA Safe Harbor de-identified, BAA included, Sunshine Act-ready. Monthly subscription with 50 interviews replaces per-project work; fielding starts the week the brief is locked.

The Problem

Why Generic CPG Research Doesn't Capture HCPs Accurately

Three structural constraints that generic consumer panels and clinician panel rentals don't solve.

01

Generic consumer panels lack license-verified clinicians

Self-identified 'nurse' or 'physician' on a generic consumer panel is structurally vulnerable to fraud and misrepresentation. PNAS 2025: AI bots evade legacy detection 99.8% of the time. For clinician-targeted CPG and HCP audience research, the verification gap leads to product strategy and creative decisions made on misrepresented respondents.

02

Any HCP work triggers BAA + Sunshine Act handling

DTC pharma brand health work, OTC claim testing with HCPs, and HCP audience research for healthcare CPG all trigger BAA execution and Sunshine Act / Open Payments-compatible data handling. Generic CPG research vendors typically don't sign BAAs at all, and clinician panel rentals require multi-year annual subscriptions before any compliance reuse compounds.

03

SKU launch and creative cycles outrun legacy panel cadence

Healthcare CPG product cycles run 6-12 weeks for new SKU launches, line extensions, and creative refreshes. DTC pharma creative iteration runs faster. Legacy clinician research at 8-12 week per-project turnaround misses iteration windows. Without same-week fielding, brand and creative teams ship without HCP signal.

04

Adherence research and package-claim testing have no native vendor stack

DTC pharma adherence drivers, OTC package-claim comprehension, and dosing-instruction usability sit between consumer UX panels (no clinical context) and pharma research vendors (no consumer cadence). Brands either commission custom mixed-methods work at 8-12 week timelines or ship adherence programs and package claims without patient or HCP signal — both paths leak SKU value at launch.

The Solution

How Does Carevoices Compress Healthcare CPG Brand Research?

Healthcare CPG, DTC pharma, and OTC brand teams use Carevoices for AI-moderated voice and video interviews with verified clinicians by specialty and workplace setting plus HCP audiences, recruited in 7-21 days, delivered as HIPAA Safe Harbor de-identified transcripts under BAA with Sunshine Act-ready data handling. A monthly subscription with 50 interviews included replaces per-project vendor work — claim testing, brand health, HCP audience research, and concept testing all run within one engagement. Compliance is built into the platform, not bolted on.

How does Carevoices recruit HCPs by workplace setting (OR vs ICU vs ambulatory)?

Panelist intake captures workplace setting, specialty, and product or category exposure. NPI auto-validated against the public NPPES Registry; license cross-checked against state board databases. For specific recruitment (e.g., 50 OR nurses who currently wear a competitor scrub brand), we pre-screen against verified panel members and supplement via direct NPI outreach. Typical recruitment: 7-14 days for mainstream specialties + workplace settings.

What makes Carevoices' compliance posture defensible for HCP CPG work?

BAA on every healthcare engagement (template available before signature). PHI-safe transcript pipeline with no model training, no logging on customer data. HIPAA Safe Harbor de-identification applied to every transcript before delivery. Sunshine Act / Open Payments-ready data handling with NPI capture at intake — for unblinded engagements, we provide CMS-format export data for your sponsor's filing. Stimuli pre-approval workflow with versioning and audit trail for FDA-relevant content.

What's structurally different about Carevoices' delivery vs. clinician panel rentals?

AI-native delivery, a monthly subscription with 50 interviews included replacing bespoke per-project vendor work, compliance-as-architecture rather than retrofit, and always-on listening capability — without multi-year panel-access lock-in. Fielding starts the same week the brief is locked. We don't replace panel rentals — we provide AI moderation, compliance posture, and de-identified delivery as an integrated stack. The structural difference shapes engagement velocity, data integrity (0.4% verified AI-respondent leak rate vs. 18-31% on benchmarked legacy panels), and SKU launch + creative cycle iteration.

Use Cases

How For Healthcare CPG, DTC Pharma & OTC Brand Teams use
Carevoices

Compliance Built In

BAA on every healthcare engagement, template available pre-signature. HIPAA Safe Harbor de-identification by default. US data residency confirmed in writing. Sunshine Act / Open Payments-ready data handling with NPI capture at intake — CMS-format export for unblinded sponsor work. Stimuli pre-approval workflow with versioning and audit trail for FDA-relevant content.

Healthcare CPG and DTC pharma compliance teams clear the engagement in 5-10 business days

Faster Insights

Fielding starts the same week the brief is locked. AI-moderated voice and video interviews with verified clinicians by specialty and workplace setting from a 10k+ healthcare panel. Recruitment takes 7-14 days for mainstream specialties + workplace settings; 14-28 days for rare combinations. Same-week fielding fits SKU launches and creative iteration cycles.

Full studies delivered in under 2 weeks vs. 8-12 weeks at legacy panel rentals

Always-On Listening

Monthly subscription with 50 interviews included means the next brand health wave fields the moment the prior study closes. Run claim testing, brand health tracking, HCP audience research, concept testing, and creative testing all within the same engagement — continuous brand health vs. point-in-time campaigns, no per-project procurement cycle between studies.

Continuous brand health tracking; iterate within SKU launch and creative cycles

Adherence Research & Package-Claim Testing

Voice and video research with patients and prescribing HCPs on adherence drop-off triggers, OTC package-claim comprehension, and dosing-instruction usability. Verified panel by condition, regimen exposure, and workplace setting. Stimuli pre-approval workflow handles regulated package and labeling content; HIPAA Safe Harbor de-identification by default.

Adherence programs and package claims ship with current patient and HCP signal, not assumptions
Compare

How Carevoices compares to common healthcare CPG research alternatives

Dimension Carevoices M3 / Sermo panel rentalsGeneric CPG research firmsListen Labs / Outset / generic AI tools
Engagement model Monthly subscription with 50 interviews included; same-week fielding; no multi-year lock-in Multi-year annual panel-access subscription + per-survey feesRFP-driven custom engagement, 30-90 day procurementCustom RFP-driven engagement design
AI-moderated voice/video qualitative Native — primary delivery mechanism Survey + community methodologyQuant-led with qualitative bolt-onYes — but no healthcare compliance package
License + NPI verified HCP panel Native — license + NPI verified at intake; workplace setting captured Yes — physician panel breadth is core to the productSelf-identified or commissioned per RFPSelf-identified — no license verification or NPI cross-check
BAA + Sunshine Act handling for HCP work Yes — template available pre-signature; CMS-format export for unblinded engagements Yes — standard for HCP engagementsSometimes — depends on vendor; not always pre-builtNo published BAA; 60-120+ day legal retrofit
Iteration speed inside SKU launch + creative cycle Multiple study types within one subscription cycle Per-survey fees on every roundNew RFP cycle per roundCustom-scoped per round; no compliance reuse
How It Works

How consumer healthcare brands use Carevoices

1
Day 1

Brief us

You define the study question and audience. Our research agent translates the brief into a structured learning plan within 24 hours; recruitment feasibility confirmed before contract.

2
Days 2–14

We recruit and moderate

AI-moderated voice or video interviews with verified clinicians. License + NPI verified at intake, behavioral fingerprinting across interviews, AI-on-AI fraud detection on every conversation.

3
Days 15–17

We de-identify and deliver

Transcripts and recordings stripped of all 18 HIPAA Safe Harbor identifiers, then delivered to your team in standard formats your existing analysis stack already accepts.

4
Days 18–21

You analyze

You analyze the de-identified data using your existing tools and team. We don't replace your analysis stack — we feed it the qualitative data your current vendors can't recruit for fast enough.

"We were CROs competing on speed alone, but patient research was the bottleneck — we would quote 8-week timelines while sponsors went to bigger firms in the US and Europe. Carevoices changed the math. We ran 1,203 patient interviews in 48 hours for one sponsor, with HIPAA-grade de-identified transcripts delivered straight into our analysis stack, and the AI moderator went deeper than our human moderators on the first round. Sponsors come to us specifically now because we can do depth research at scale — 34% recruitment uplift, 52% retention. We can now compete globally because of Carevoices."

Stephane Nyombaire, CEO, Nivella Health

Methodology & Trust

The Carevoices Difference for Healthcare CPG Research

Generic AI research tools and consumer-grade CPG research platforms can be retrofit for healthcare CPG and DTC pharma engagements — but the retrofit shows. Carevoices is built around healthcare compliance and clinician verification from day one. Here's how the architecture compares.

Carevoices Healthcare-Vertical Architecture

  • BAA on every healthcare engagement, template available pre-signature
  • License + NPI verified clinician panel (NPPES Registry cross-check at intake)
  • Workplace setting filters honored at recruitment (OR, ICU, NICU, Onc, ASC, ambulatory, private practice)
  • HIPAA Safe Harbor de-identification built into delivery pipeline
  • Sunshine Act / Open Payments-ready data handling — NPI capture + CMS-format export
  • Stimuli pre-approval workflow with versioning and audit trail for FDA-relevant content
  • 0.4% verified AI-respondent leak rate via 6-Layer Fraud Detection Stack
  • PHI never trains a model — period

What Generic AI Research Tools Require

  • BAA execution often unavailable or 60-120+ day legal retrofit
  • Self-identified panel without license verification or NPI cross-check
  • Workplace setting either unfiltered or self-reported without verification
  • De-identification typically a post-fielding service charge or skipped entirely
  • Sunshine Act handling not built; bolt-on per engagement
  • No native stimuli pre-approval workflow for FDA-relevant content
  • Legacy fraud detection that PNAS 2025 shows AI bots evade 99.8% of the time
  • PHI in model training pipeline unless explicitly contracted otherwise

In progress: SOC 2 Type II audit (in evidence-collection phase). HITRUST CSF and ISO 27001 are 2026-2027 roadmap. Letter of audit attestation available on request to qualified prospects under NDA.

Get Started

Run your next brand or HCP study the week the brief is locked

Walk through your current brand and HCP research backlog. See how the monthly subscription fits SKU launch and creative cycles. Get a sample compliant deliverable from a recent engagement.

30-min with founder

Walkthrough of a sample compliant deliverable and how the monthly subscription fits your SKU launch and creative cycles

For your brand team

Sample HIPAA-grade de-identified transcript and analysis from a recent HCP audience or brand health engagement

For your legal team

BAA template, HIPAA Safe Harbor methodology, US data residency commitment, Sunshine Act handling

Most engagements clear healthcare CPG and DTC pharma procurement within 30 days.

FAQ

Common questions

Yes. BAA is standard on every healthcare engagement, included in every contract. Custom terms accommodated when your legal team needs them. Template available on request before signature. Most BAAs execute within 5-10 business days.
Default-blinded studies — your team never learns participant identity, so transfers of value typically don't trigger reporting. For unblinded engagements, we provide CMS-format export data for your sponsor's filing. Our panelist intake captures NPI, state license, specialty, and address — export-ready by design.
For consumer-only brand research without HCP exposure or PHI, BAA is not strictly required. We still apply HIPAA Safe Harbor de-identification by default and capture US data residency commitments in the standard contract. Any HCP work triggers BAA execution as part of standard handling.
Self-identification on generic consumer panels is structurally vulnerable to AI-respondent fraud and misrepresentation. PNAS 2025 research shows AI bots evade legacy detection 99.8% of the time. Our Q3 2025 audit measured 18-31% AI-respondent leak rates on benchmarked legacy consumer panels. For brand strategy and creative decisions informed by HCP audience research, the verification gap is material data integrity risk.
M3, Sermo, and Reckner Healthcare panel rentals require multi-year subscriptions structured around quant trackers — not agile qualitative work. Carevoices delivers a monthly subscription with 50 interviews included (same-week fielding, BAA, Sunshine Act-ready). Claim testing, brand health tracking, HCP audience research, and creative testing all run within the subscription at AI-native velocity, no multi-year lock-in.
M3 and Sermo are panel-access subscriptions — annual fees for survey rights, plus per-survey fees, with you assembling moderation and de-identification. Carevoices is a delivered-study subscription where recruitment, AI voice/video, transcription, HIPAA Safe Harbor, BAA, and Sunshine Act are bundled. M3 and Sermo are stronger for international tracker breadth; Carevoices is built for qualitative work where same-week fielding and built-in compliance matter more.
Generic AI research tools were built for consumer brands and haven't retrofit healthcare compliance as core architecture. Most don't publish a BAA template, don't run license + NPI verification at intake, don't honor workplace-setting filters, don't de-identify to HIPAA Safe Harbor by default, and don't have stimuli pre-approval for FDA-relevant content. Healthcare CPG and DTC pharma compliance typically disqualifies them at the BAA gate, or accepts a 60-120+ day retrofit per engagement.
Yes. Custom panel mix accommodated within the monthly subscription for cross-specialty research. Discuss specific audience composition on demo call.
Explore More

Go deeper on For Healthcare CPG, DTC Pharma & OTC Brand Teams